InvestorsHub Logo
Followers 113
Posts 17525
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Thursday, 03/14/2024 6:29:26 AM

Thursday, March 14, 2024 6:29:26 AM

Post# of 602
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline